{"disease":{"id":"furmonertinib","name":"furmonertinib"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07348965","title":"Pulsatile High-dose Furmonertinib in EGFR-mutant NSCLC With Leptomeningeal Metastasis","phase":"NA","overall_status":"RECRUITING","enrollment_count":42,"lead_sponsor_name":"Guangzhou University of Traditional Chinese Medicine","has_results":false},{"nct_id":"NCT05465343","title":"Furmonertinib in EGFR-Mutant NSCLC With Brain Metastases (iFORCE)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Peking Union Medical College","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}